Antagonizing the Cannabinoid Receptor Type 1: a Dual Way to Fight Obesity

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 2004 Feb 5

PMID 14759080

Citations 11

Authors

D Cota

S Genghini

R Pasquali

U Pagotto

Affiliations

Soon will be listed here.

Citing Articles

Characterization of the effects of cannabinoid receptor deletion on energy metabolism in female C57BL mice.

Sotzen M, Ahmed A, Olson L, Alshaarawy O Front Endocrinol (Lausanne). 2024; 15:1386230.

PMID: 38962676 PMC: 11221337. DOI: 10.3389/fendo.2024.1386230.

Cannabinoids and Chronic Liver Diseases.

Mboumba Bouassa R, Sebastiani G, Di Marzo V, Jenabian M, Costiniuk C Int J Mol Sci. 2022; 23(16).

PMID: 36012687 PMC: 9408890. DOI: 10.3390/ijms23169423.

Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist.

Muller T, Demizieux L, Troy-Fioramonti S, Buch C, Leemput J, Belloir C Int J Mol Sci. 2022; 23(6).

PMID: 35328343 PMC: 8949893. DOI: 10.3390/ijms23062923.

At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk.

Khan R, Maner-Smith K, Owens J, Barbian M, Jones R, Naudin C Gut Microbes. 2021; 13(1):1-21.

PMID: 33896380 PMC: 8078674. DOI: 10.1080/19490976.2021.1911572.

On the Role of Central Type-1 Cannabinoid Receptor Gene Regulation in Food Intake and Eating Behaviors.

Pucci M, Zaplatic E, Micioni Di Bonaventura M, Micioni Di Bonaventura E, De Cristofaro P, Maccarrone M Int J Mol Sci. 2021; 22(1).

PMID: 33401515 PMC: 7796374. DOI: 10.3390/ijms22010398.

References

Kirkham T, Williams C, Fezza F, Di Marzo V . Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol. 2002; 136(4):550-7. PMC: 1573386. DOI: 10.1038/sj.bjp.0704767. View

Cota D, Marsicano G, Lutz B, Vicennati V, Stalla G, Pasquali R . Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord. 2003; 27(3):289-301. DOI: 10.1038/sj.ijo.0802250. View

Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M . The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest. 2003; 112(3):423-31. PMC: 166293. DOI: 10.1172/JCI17725. View

Werner N, Koch J . Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats. Brain Res. 2003; 967(1-2):290-2. DOI: 10.1016/s0006-8993(02)04274-9. View

Hill J, Wyatt H, Reed G, Peters J . Obesity and the environment: where do we go from here?. Science. 2003; 299(5608):853-5. DOI: 10.1126/science.1079857. View

Harrold J, Elliott J, King P, Widdowson P, Williams G . Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?. Brain Res. 2002; 952(2):232-8. DOI: 10.1016/s0006-8993(02)03245-6. View

Marx J . Cellular warriors at the battle of the bulge. Science. 2003; 299(5608):846-9. DOI: 10.1126/science.299.5608.846. View

Lyon C, Law R, Hsueh W . Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003; 144(6):2195-200. DOI: 10.1210/en.2003-0285. View

Gura T . Obesity drug pipeline not so fat. Science. 2003; 299(5608):849-52. DOI: 10.1126/science.299.5608.849. View

10.

Bensaid M, Gary-Bobo M, Esclangon A, Maffrand J, Le Fur G, Oury-Donat F . The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol. 2003; 63(4):908-14. DOI: 10.1124/mol.63.4.908. View

11.

Hildebrandt A, Kelly-Sullivan D, Black S . Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol. 2003; 462(1-3):125-32. DOI: 10.1016/s0014-2999(03)01343-8. View

12.

Liu J, Li H, Burstein S, Zurier R, Chen J . Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. Mol Pharmacol. 2003; 63(5):983-92. DOI: 10.1124/mol.63.5.983. View

13.

Di Marzo V, Goparaju S, Wang L, Liu J, Batkai S, Jarai Z . Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature. 2001; 410(6830):822-5. DOI: 10.1038/35071088. View

14.

Gomez R, Navarro M, Ferrer B, Trigo J, Bilbao A, Del Arco I . A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci. 2002; 22(21):9612-7. PMC: 6758016. View

15.

Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand J . Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol. 2002; 284(2):R345-53. DOI: 10.1152/ajpregu.00545.2002. View

16.

Kirkham T, Williams C . Endogenous cannabinoids and appetite. Nutr Res Rev. 2008; 14(1):65-86. DOI: 10.1079/NRR200118. View

17.

Howlett A, Barth F, Bonner T, Cabral G, Casellas P, Devane W . International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002; 54(2):161-202. DOI: 10.1124/pr.54.2.161. View